Inventor
ROSSI BENJAMIN
FR20 patents
⚠️ This page may combine multiple inventors who share the name “ROSSI BENJAMIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INNATE PHARMA
19 patentsUS10113003B2Oct 30, 2018
Multispecific NK engager proteins
INNATE PHARMA15 citations91
US10577419B2Mar 3, 2020
KIR3DL2 binding agents
INNATE PHARMA15 citations90
US11267897B2Mar 8, 2022
Multispecific NK engager protein
INNATE PHARMA8 citations84
US10246510B2Apr 2, 2019
KIR3DL2 binding agents
INNATE PHARMA9 citations83
US11001629B2May 11, 2021
Variable regions for NKp46 binding proteins
INNATE PHARMA7 citations82
US10519234B2Dec 31, 2019
NKp46 binding proteins
INNATE PHARMA6 citations82
US9828427B2Nov 28, 2017
Anti-KIR3D antibodies
INNATE PHARMA9 citations80
US11891444B2Feb 6, 2024
Variable regions for NKp46 binding proteins
INNATE PHARMA3 citations73
US11208480B2Dec 28, 2021
Multispecific antigen binding proteins
INNATE PHARMA3 citations73
US11377503B2Jul 5, 2022
Antibodies that bind human CD39 and inhibit ATPase activity of a soluble extracellular domain human CD39 polypeptide
INNATE PHARMA3 citations70
US11858990B2Jan 2, 2024
KIR3DL2 binding agents
INNATE PHARMA2 citations69
US11078274B2Aug 3, 2021
Siglec neutralizing antibodies
INNATE PHARMA3 citations68
US12252543B2Mar 18, 2025
Multispecific NK engager protein
INNATE PHARMA0 citations61
US11845795B2Dec 19, 2023
NKp46 binding proteins
INNATE PHARMA1 citations61
US11623954B2Apr 11, 2023
Siglec-9-neutralizing antibodies
INNATE PHARMA1 citations60
US12202907B2Jan 21, 2025
Nucleic acids encoding and methods of producing proteins comprising antibody chains
INNATE PHARMA0 citations59
US11578136B2Feb 14, 2023
Compositions and methods for treating cancer
INNATE PHARMA1 citations59
US11083785B2Aug 10, 2021
Siglec-10 antibodies
INNATE PHARMA1 citations59
US11447545B2Sep 20, 2022
Combination therapy using antibody to human Siglec-9 and antibody to human NKG2A for treating cancer
INNATE PHARMA0 citations49